Open original FDA record ↗Recall record
- FDA identifier
- Z-1750-2015
- Company in FDA record
- ResMed Ltd.
- FDA classification date
- Jun 10, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The Astral device allows clinicians to disable all alarms including those that detect circuit disconnection. Inappropriate disabling of alarms in ventilator dependent patients can lead to hazards of insufficient ventilation and insufficient expiratory pressure which can result in major severity harm.
Source facts
- Action
- A customer notification letter dated 5/5/15 will be sent to customers that the Astral device allows clinicians to disable all alarms including those that detect circuit disconnection. The letter provides the customers with the hazards involved and the actions to be taken. Customers are instructed to ensure alarms are appropriately set up for ventilator dependent patients. Customers with questions are instructed to contact Larissa D'Andrea at (858) 836-6837 or email larissa.d'andrea@resmed.com.
- Initiated
- 2015-05-05
- Root cause
- Use error
- Terminated
- 2016-04-07
- Distribution
- Worldwide distribution. US nationwide, Uruguay and Canada.
- Recall number
- Z-1750-2015
- Recall status
- Terminated
- CDRH record ID
- 136099
- FDA classified
- 2015-06-10
- Recall event number
- 71100